Saltar al contenido
Merck
  • Enhanced transcellular penetration and drug delivery by crosslinked polymeric micelles into pancreatic multicellular tumor spheroids.

Enhanced transcellular penetration and drug delivery by crosslinked polymeric micelles into pancreatic multicellular tumor spheroids.

Biomaterials science (2015-07-30)
Hongxu Lu, Robert H Utama, Uraiphan Kitiyotsawat, Krzysztof Babiuch, Yanyan Jiang, Martina H Stenzel
RESUMEN

Many attempts have been made in the application of multicellular tumor spheroids (MCTS) as a 3D tumor model to investigate their biological responses upon introduction of polymeric micelles as nanocarriers for therapeutic applications. However, the micelle penetration pathways in MCTS are not yet known. In this study, micelles (uncrosslinked, UCM) were prepared by self-assembly of block copolymer poly(N-(2-hydroxypropyl) methacrylamide-co-methacrylic acid)-block-poly(methyl methacrylate) (P(HPMA-co-MAA)-b-PMMA). Subsequently, the shells were crosslinked to form relatively stable micelles (CKM). Both UCM and CKM penetrated deeper and delivered more doxorubicin (DOX) into MCTS than the diffusion of the free DOX. Additionally, CKM revealed higher delivery efficiency than UCM. The inhibition of caveolae-mediated endocytosis, by Filipin treatment, decreased the uptake and penetration of the micelles into MCTS. Treatment with Exo1, an exocytosis inhibitor, produced the same effect. Furthermore, movement of the micelles through the extracellular matrices (ECM), as modelled using collagen micro-spheroids, appeared to be limited to the peripheral layer of the collagen spheroids. Those results indicate that penetration of P(HPMA-co-MAA)-b-PMMA micelles depended more on transcellular transport than on diffusion through ECM between the cells. DOX-loaded CKM inhibited MCTS growth more than their UCM counterpart, due to possible cessation of endocytosis and exocytosis in the apoptotic peripheral cells, caused by faster release of DOX from UCM.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Acida sódica, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Doxorrubicina hydrochloride, 98.0-102.0% (HPLC)
Sigma-Aldrich
1,2-Dicloroetano, anhydrous, 99.8%
Sigma-Aldrich
Metilmetacrilato, contains ≤30 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
N,N-Dimetilacetamida, ReagentPlus®, ≥99%
Sigma-Aldrich
2-Desoxi-D-glucosa, ≥98% (GC), crystalline
Sigma-Aldrich
Methacrylic acid, contains 250 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
Acida sódica, BioUltra, ≥99.5% (T)
Sigma-Aldrich
N,N-Dimetilformamida, Molecular Biology, ≥99%
Sigma-Aldrich
2-Desoxi-D-glucosa, ≥99% (GC), crystalline
Sigma-Aldrich
Acida sódica, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Doxorrubicina hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
Sigma-Aldrich
Acida sódica, BioXtra
Sigma-Aldrich
Chlorpromazine hydrochloride, ≥98% (TLC)
Sigma-Aldrich
Dietiléter
Sigma-Aldrich
Metilmetacrilato, 99%, stabilized
Sigma-Aldrich
1,8-Diaminooctane, 98%
Sigma-Aldrich
N,N-Dimetilacetamida, suitable for peptide synthesis, ≥99.8% (GC)
Sigma-Aldrich
2-Desoxi-D-glucosa, ≥98% (GC), BioXtra
SAFC
N,N-Dimetilacetamida, Ph. Eur.
Sigma-Aldrich
Fluorescein O-methacrylate, 95%
Sigma-Aldrich
N,N-Dimethylacetamide-d9, 99 atom % D
Sigma-Aldrich
Metanol, suitable for NMR (reference standard)
Sigma-Aldrich
Chlorpromazine hydrochloride, meets USP testing specifications
Sigma-Aldrich
N-(2-Hydroxypropyl)-2-methyl-prop-2-enamide, AldrichCPR